Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte- macrophage receptor

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 6, 1998, Pages 968-976

  Gianturco, Sandra H ^a,c   Ramprasad, M P ^b   Song, Ruiling ^a   Li, Ran ^d   Brown, Matthew L ^a   Bradley, William A ^a,c  

^a Center for Palliative Care   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NONE

Author keywords

Atherosclerosis; Foam cells; Hypertriglyceridemia

Indexed keywords

CHYLOMICRON;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; FOAM CELL; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0031776659     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.6.968     Document Type: Article

References (14)

1. Havel RJ. Role of the liver in atherosclerosis. Arteriosclerosis. 1985;5: 569-580.
2. Naito M, Wisse E. Filtration effect of endothelial fenestrations on chylomicron transport in neonatal rat liver sinusoids. Cell Tissue Res. 1978; 190:371-382.
3. Hamilton RL, Wong JS, Guo LS, Krisans S, Havel RJ. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. J Lipid Res. 1990;31:1589-1603.
4. Ross CA, Zilversmit DB. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J Lipid Res. 1977;18:169-181.
5. Nagata Y, Zilversmit DB. Blockade of intestinal lipoprotein clearance in rabbits injected with Triton WR 1339-ethyl oleate. J Lipid Res. 1987;8:684-692.
6. Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits: factors that modify tissue-specific uptake. J Biol Chem. 1989;264:9571-9582.
7. Hussain MM, Mahley RW, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL. Chylomicron metabolism: chylomicron uptake by bone marrow in different animal species. J Biol Chem. 1989;264:17931-17938.
8. Blomhoff R, Green MH, Norum KR. Vitamin A: physiological and biochemical processing. Annu Rev Nutr. 1992;12:37-57.
9. Fredrickson DS, Goldstein JL, Brown MS. The familial hyperlipoproteinemias. In: Stanbury JG, Wyngaarden MF, Fredrickson DS, eds. The Metabolic Basis of Inherited Diseases. New York, NY: McGraw-Hill Publishing Co; 1978:604-655.
10. Parker F, Bagdade JD, Odland GF, Bierman EL. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970;49:2172-2187.
11. Gianturco SH, Brown FP, Gotto AM Jr, Bradley WA. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J Lipid Res. 1982;23:984-993.
12. f 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem. 1983;258:4526-4533.
13. Bradley WA, Hwang SC, Karlin JB, Lin AH, Prasad SC, Gotto AM Jr, Gianturco SH. Low density lipoprotein (LDL) receptor binding determinants switch from apolipoprotein E (apoE) to apoB during conversion of hypertriglyceridemic very low density lipoprotein (HTG-VLDL) to LDL. J Biol Chem. 1984;259:14728-14735.
14. Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G. Roles of apoproteins B and E in the cellular binding of very low density lipoproteins. J Clin Invest. 1985;75:361-369.